PHASE
Tapping into the secrets of successful clinical development
May 29th-June 1st 2012
Boston
Ask any drug developers and they will agree that the momentum carried into, and out of, clinical development is crucial to both success in the clinic and commercial outcome. Yet drug developers are still struggling to design and execute in two key areas:
Despite the struggle, there is very little awareness of the potential solutions that are available to support drug developers in both of these critical phases of clinical development. Pharmaceutical companies have often been slow to adapt, and as a consequence, there is a sense in the industry that clinical trials are more complex and uncertain than ever.
That situation is changing rapidly. Increasing regulatory requirements, decreasing drug approvals, personalized medicine, the demise of the blockbuster (and rise of the niche drug), and a myriad of new game-changing technologies and opportunities mean that drug developers are quickly re-evaluating how they design and execute clinical trials.
And who they work with.
PHASE comprises of two distinct events with one exhibition space designed to address the two pivotal stages of clinical development:
With speakers confirmed from the likes of Merck, Sanofi, Johnson & Johnson, Roche, Takeda and many others, expect 120-150 clinical development leaders and experts, all searching for the very latest ideas, solutions, products and connections that will support them to make the most out of their clinical development programs.

For more information on each event, visit the following event-specific websites:
Early Stage Clinical Development Summit
Late Stage Clinical Development Summit
Download the agenda to see more detail on the topics being covered
Something you want to share; white papers, articles or interested in speaking? Then let us know... just email any questions to info@hansonwade.com
Get the best rates by booking now to ensure your place at this unique meeting - Book online or call +1 212 537 5898.
“That was the best event I have ever attended. I don’t usually consider commercial events but that was very good. You have a committed customer from this point onwards” Sanofi
“Very valuable and useful information. One of the best meetings I’ve ever attended.” Millennium
“Strong program, great speakers and a genuine focus on identifying solutions” Novartis
“It exceeded my expectations. The talks were high quality and the interaction among participants was excellent.” Genentech
“An effective forum to network and learn the most recent progress on several areas” MedImmune
“An exciting set of insightful talks on a broad array of topics” Eli Lilly
“A great place to get latest information and networking” Pfizer
“An excellent opportunity to find out what other pharma are doing and what’s emerging. Very valuable.” AstraZeneca